Subclassification of MSI-H colon cancer patients according to B2M mutation status revealed that B2M wild-type MSI-H colon cancer patients were comparable to MSS colon cancer patients with regard to TTR. The gene discussed is B2M; the disease is malignant colon neoplasm.